Medical Market Report

Global Pneumococcal Polysaccharide Vaccine Market By Type (Single Dose Vial, and Pre-Filled Syringe), By Application (Children (2-10 Age), Adult (10-64 Age), and Geriatric (More Than 65 Age)), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139384
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Pneumococcal Polysaccharide Vaccine Market is estimated to be valued US$ XX.X million in 2019. The report on Pneumococcal Polysaccharide Vaccine Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global pneumococcal polysaccharide vaccine market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Pneumococcal Polysaccharide Vaccine Market Scope:

    By type, the market is segmented into Single Dose Vial, and Pre-Filled Syringe. By Application, the market is divided into Children (2-10 Age), Adult (10-64 Age), and Geriatric (More Than 65 Age).
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Merck, Pfizer, GlaxoSmithKline, Sanofi Pasteur, China National Biotec Group, Astellas Pharma, and Serum Institute of India.

    Key Market Segments

    Type

    Single Dose Vial

    Pre-Filled Syringe

    Application

    Children (2-10 Age)

    Adult (10-64 Age)

    Geriatric (More Than 65 Age)

    Key Market Players included in the report:

    Merck

    Pfizer

    GlaxoSmithKline

    Sanofi Pasteur

    China National Biotec Group

    Astellas Pharma

    Serum Institute of India

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Pneumococcal Polysaccharide Vaccine Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Pneumococcal Polysaccharide Vaccine Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Pneumococcal Polysaccharide Vaccine Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Pneumococcal Polysaccharide Vaccine Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Pneumococcal Polysaccharide Vaccine Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Pneumococcal Polysaccharide Vaccine Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Pneumococcal Polysaccharide Vaccine sub-markets, depending on key regions (various vital states).
    To analyze Pneumococcal Polysaccharide Vaccine Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Pneumococcal Polysaccharide Vaccine Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Pneumococcal Polysaccharide Vaccine Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Pneumococcal Polysaccharide Vaccine Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Pneumococcal Polysaccharide Vaccine Market Overview
    

    3.1. Pneumococcal Polysaccharide Vaccine Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Pneumococcal Polysaccharide Vaccine Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Pneumococcal Polysaccharide Vaccine Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Single Dose Vial
    

      4.4. Pre-Filled Syringe
    

    5. Global Pneumococcal Polysaccharide Vaccine Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Pneumococcal Polysaccharide Vaccine Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Children (2-10 Age)
    

      5.4. Adult (10-64 Age)
    

      5.5. Geriatric (More Than 65 Age)
    

    6. Global Pneumococcal Polysaccharide Vaccine Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Pneumococcal Polysaccharide Vaccine Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Pneumococcal Polysaccharide Vaccine Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Pneumococcal Polysaccharide Vaccine Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Pneumococcal Polysaccharide Vaccine Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Pneumococcal Polysaccharide Vaccine Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Pneumococcal Polysaccharide Vaccine Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Merck
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Pfizer
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. GlaxoSmithKline
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Sanofi Pasteur
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. China National Biotec Group
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Astellas Pharma
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Serum Institute of India
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.